MiniMed™ 770G System Insulin Pump Technology

Self-adjusting technology approved for ages 2 and older.* Now with smartphone connectivity.




The new MiniMed™ 770G system automatically adjusts insulin levels and takes on more of the tasks of managing diabetes so your patients can focus more on their daily lives.*

  • PREDICTS: Monitors sugar levels 24/7 and predicts highs and lows in advance.

  • ADAPTS: Continuously adapts to insulin needs based on real-time data and personal trends.

  • SELF-ADJUSTS: Smooths out highs and lows, with SmartGuard™ tech that increases or decreases insulin delivery, every five minutes.

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

Icon with arrow facing up.


Any customer using the MiniMedTM 770G system will get access to our next technology, when available, at no cost through October 27, 2022. Our next innovation goal is to reduce fingersticks and bring you an advanced algorithm with auto-correction bolus for easier mealtimes. Get access to the future by filling out the form below and learning more about the MiniMedTM 770G system.
Click here to learn about our future innovations.

MinimeD™ 770G System overview


The MiniMed 770G system displayed on body with mobile app and Quickset.

1. Insulin Pump

SmartGuard™ Auto Mode automatically adjusts insulin delivery.* It helps predict highs and lows in advance and increases or decreases insulin delivery. Now with smartphone connectivity.

2. Infusion Set 

Allows for continuous and discreet delivery of insulin through a thin, flexible tube.

3. Continuous Glucose Monitor (CGM)

The Guardian™ Sensor 3 measures sugar levels every 5 minutes and automatically sends information to the pump.

4. Smartphone Apps

The MiniMed™ Mobile app provides discretion and convenience for the patient. The CareLink™ Connect app allows up to five care partners to see insulin, pump and CGM data.

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

Automatic CareLink™ data uploads


The MiniMed™ 770G system with Bluetooth® connectivity enables automatic CareLink™ uploads, helping support meaningful conversations with your patients, whether in-person or via telehealth.



  • Your patients’ data can now be easily uploaded prior to their appointments.


  • Providing access to insights for your patients’ therapy adjustments.


  • Giving you and your patients the ability to view data whenever needed.



Smartphone Connectivity Enables New Features

The MiniMed™ Mobile app and CareLink™ Connect app help your patients and their families live more and worry less. 




Your patients can now use their smartphones to view their data. This means they can easily and discreetly track their glucose levels and get notified of highs and lows.



carelink™ connect APP

Available for care partners, this app helps keep everyone in the loop. Up to five care partners can now follow a pump user and receive high and low notifications.



SmartGuard™ Auto Mode

Automatically Adjusts Insulin Levels Every 5 Minutes

Each day and night, insulin needs vary.

By constantly adapting to real-time glucose needs, SmartGuard™ technology automatically adjust basal insulin to help keep your patients in target glucose range.*

A graph showing night 1 on the 770G system.
A graph showing night 3 on the 770G system.
A graph showing night 2 on the 770G system.
A graph showing night 4 on the 770G system.

CareLinkTM Patient Representative Profile

Expand All




Complete the form below and a sales representative will follow up with additional information.

* Indicates a required field.

By clicking Submit, I confirm that I have read and agree to the Authorization and permit Medtronic to use my contact information for the purposes described in the authorization. Read More.

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

Software Upgrade Terms and Conditions

  • This program allows MiniMedTM 770G system customers a software upgrade at no charge through. October 27, 2022.
  • Software upgrade process is subject to change and may result in healthcare provider office visit and may result in out-of-pocket expenses such as co-pay, depending on insurance coverage.
  • MiniMedTM pumps and software have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding your eligibility to receive the software upgrade based on the labeling of the upgrade, which may differ from the labeling of the MiniMed™ 770G pump.
  • This program applies to the insulin pump software only. Continuous Glucose Monitor products and consumables are not included in this offer.
  • A valid prescription will be required for this software upgrade. All participants should consult their healthcare provider for all therapy related decisions.
  • Warranty dates do not reset. The replacement warranty date of an insulin pump upgraded with the software will remain the same as the replacement warranty date of the initial pump purchased.
  • Insurance coverage and plan design varies and may impact the ability to upgrade. Coverage is contingent upon your health insurance medical policy guidelines. Restrictions and medical necessity requirements may apply.
  • Program terms and conditions are subject to change at any time and without notice. Other restrictions may apply.

Important Safety Information: MiniMedTM 770G System with SmartGuardTM Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.”

©2020 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.